310 related articles for article (PubMed ID: 33684427)
1. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
3. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
4. Gut microbiome and mycobiome in inflammatory bowel disease patients with
Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
[TBL] [Abstract][Full Text] [Related]
5. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
7. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
8. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
[TBL] [Abstract][Full Text] [Related]
9. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
[TBL] [Abstract][Full Text] [Related]
10. Fungal and bacterial gut microbiota differ between
Henderickx JGE; Crobach MJT; Terveer EM; Smits WK; Kuijper EJ; Zwittink RD
Microbiome Res Rep; 2024; 3(1):8. PubMed ID: 38455084
[No Abstract] [Full Text] [Related]
11. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
[TBL] [Abstract][Full Text] [Related]
12. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
13. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
[TBL] [Abstract][Full Text] [Related]
14. Early gut mycobiota and mother-offspring transfer.
Schei K; Avershina E; Øien T; Rudi K; Follestad T; Salamati S; Ødegård RA
Microbiome; 2017 Aug; 5(1):107. PubMed ID: 28837002
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
16. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
[TBL] [Abstract][Full Text] [Related]
17. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
[TBL] [Abstract][Full Text] [Related]
18. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
[TBL] [Abstract][Full Text] [Related]
20. Disordered Intestinal Microbial Communities During
Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
